CASI Pharmaceuticals CASIF
OTC CASIF
$0.10 +0.00 (+0.05%)
As of: Oct 21, 2026 · 10:56 AM EDT

CASI Pharmaceuticals (CASIF) Receivables - Other (2021 - 2025)

Updated

CASI Pharmaceuticals' Receivables - Other came in at $587 billion for Q4 2024, compared with -$587,000 a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Receivables - Other (2021 - 2025) Analysis & Trends

Going back to Q4 2021, CASI Pharmaceuticals' Receivables - Other data covers 9 quarters.

  • Receivables - Other carries a four-year compound annual growth rate of 4425.1% (FY2020 to FY2024).
  • Going back by year, Receivables - Other was -$587,000 in FY2023, $60,000 in FY2022 (-59.5%), $148,000 in FY2021 (+5.7%) and $140,000 in FY2020.
  • The Q4 2024 figure represents the highest quarterly Receivables - Other in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CASI Pharmaceuticals 1.86 Mn -18.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 779,000.00
Dec 31, 2024 779,000.00
Jun 30, 2024 963,000.00
Mar 31, 2024 209,000.00
Dec 31, 2023 587,000.00
Dec 31, 2022 60,000.00
Sep 30, 2022 60,000.00
Jun 30, 2022 60,000.00
Mar 31, 2022 37,000.00
Dec 31, 2021 148,000.00
API Access

CASI Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CASIF&period=max&api_key=YOUR_API_KEY